Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int Immunopharmacol ; 22(2): 505-14, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25102307

ABSTRACT

We investigated the protective effects of lentinan against damages to chronic and low-dose radiation (CL-radiation) by using mouse models. The mice were randomized divided into four groups: normal control mice (Ctr), mice exposed to radiation (Rad), irradiated mice treated with low-dose lentinan (0.1mg/(kg.d), RL), and irradiated mice treated with high-dose lentinan (0.5mg/(kg.d), RH). All the mice were injected intraperitoneally once a day at a dose of 0.5mL (Ctr and Rad with normal sodium while RL and RH with lentinan). The success of radiation models was confirmed by HE stain and cell morphology by a transmission electron microscope (TEM). On the basis of radiation models, we investigated the expression of proteins on the membrane of splenic cells through MALDI-TOF-MS/MS. The results demonstrated that both RT-radiation and lentinan affected the expression of membrane proteins, but lentinan protected the splenic cells and tissue from the injuries caused by CL-radiation. Therefore, we speculated that CL-radiation mainly damages the genetic materials and membrane-bound proteins, while lentinan protects membrane-bound proteins by regulating signal transduction and the appearance of the cells.


Subject(s)
Lentinan/pharmacology , Lymphocytes/drug effects , Lymphocytes/radiation effects , Membrane Proteins/metabolism , Radiation-Protective Agents/pharmacology , Animals , Lymphocytes/metabolism , Male , Mice , Spleen/cytology , Whole-Body Irradiation
SELECTION OF CITATIONS
SEARCH DETAIL
...